Your browser doesn't support javascript.
loading
The type 2 diabetes gene product STARD10 is a phosphoinositide-binding protein that controls insulin secretory granule biogenesis.
Carrat, Gaelle R; Haythorne, Elizabeth; Tomas, Alejandra; Haataja, Leena; Müller, Andreas; Arvan, Peter; Piunti, Alexandra; Cheng, Kaiying; Huang, Mutian; Pullen, Timothy J; Georgiadou, Eleni; Stylianides, Theodoros; Amirruddin, Nur Shabrina; Salem, Victoria; Distaso, Walter; Cakebread, Andrew; Heesom, Kate J; Lewis, Philip A; Hodson, David J; Briant, Linford J; Fung, Annie C H; Sessions, Richard B; Alpy, Fabien; Kong, Alice P S; Benke, Peter I; Torta, Federico; Teo, Adrian Kee Keong; Leclerc, Isabelle; Solimena, Michele; Wigley, Dale B; Rutter, Guy A.
Affiliation
  • Carrat GR; Section of Cell Biology and Functional Genomics, Imperial College London, du Cane Road, London, W12 0NN, UK.
  • Haythorne E; Section of Cell Biology and Functional Genomics, Imperial College London, du Cane Road, London, W12 0NN, UK.
  • Tomas A; Section of Cell Biology and Functional Genomics, Imperial College London, du Cane Road, London, W12 0NN, UK.
  • Haataja L; Division of Metabolism, Endocrinology & Diabetes, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.
  • Müller A; Molecular Diabetology, University Hospital and Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany; Paul Langerhans Institute Dresden (PLID) of the Helmholtz Center Munich, University Hospital Carl Gustav Carus and Faculty of Medicine of the TU Dresden, Dresden, Germany; German Cente
  • Arvan P; Division of Metabolism, Endocrinology & Diabetes, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.
  • Piunti A; Section of Cell Biology and Functional Genomics, Imperial College London, du Cane Road, London, W12 0NN, UK; Lille 1 University-Science and Technology, Cité Scientifique, 59655, Villeneuve d'Ascq Cedex, France.
  • Cheng K; Section of Structural Biology, Department of Medicine, Imperial College London, London, UK.
  • Huang M; Section of Cell Biology and Functional Genomics, Imperial College London, du Cane Road, London, W12 0NN, UK.
  • Pullen TJ; Section of Cell Biology and Functional Genomics, Imperial College London, du Cane Road, London, W12 0NN, UK; Department of Diabetes, Faculty of Life Science and Medicine, King's College London, London, UK.
  • Georgiadou E; Section of Cell Biology and Functional Genomics, Imperial College London, du Cane Road, London, W12 0NN, UK.
  • Stylianides T; Loughborough University, Centre of Innovative and Collaborative Construction Engineering, Leicestershire, LE11 3TU, UK.
  • Amirruddin NS; Stem Cells and Diabetes Laboratory, Institute of Molecular and Cell Biology (IMCB), A∗STAR, Proteos, Singapore, 138673, Singapore; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119228, Singapore.
  • Salem V; Section of Cell Biology and Functional Genomics, Imperial College London, du Cane Road, London, W12 0NN, UK; Section of Investigative Medicine, Department of Medicine, Imperial College London, du Cane Road, London, W12 0NN, UK.
  • Distaso W; Imperial College Business School, Imperial College London, Exhibition Road, London, SW7 2AZ, UK.
  • Cakebread A; London Metallomics Facility, King's College London, Strand, London, WC2R 2LS, UK.
  • Heesom KJ; Proteomics Facility, University of Bristol, Bristol, UK.
  • Lewis PA; Proteomics Facility, University of Bristol, Bristol, UK.
  • Hodson DJ; Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK; Institute of Metabolism and Systems Research, University of Birmingham, Edgbaston, UK; Centre of Membrane Proteins and Receptors, University of Birmingham and University of Nottingham, Midlands, UK.
  • Briant LJ; Oxford Centre for Diabetes, Endocrinology, and Metabolism, Radcliffe Department of Medicine, University of Oxford, Churchill Hospital, Oxford, OX3 7LE, UK.
  • Fung ACH; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong.
  • Sessions RB; School of Biochemistry, Faculty of Life Sciences, University of Bristol, Bristol, BS8 1TD, UK.
  • Alpy F; Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Institut National de la Santé et de la Recherche Médicale (INSERM) U1258, Centre National de la Recherche Scientifique (CNRS), UMR 7104, Université de Strasbourg, 1 rue Laurent Fries, 67404 Illkirch, France.
  • Kong APS; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong.
  • Benke PI; Singapore Lipidomics Incubator, Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, 8 Mdical Drive, Singapore, 117596, Singapore.
  • Torta F; Singapore Lipidomics Incubator, Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, 8 Mdical Drive, Singapore, 117596, Singapore.
  • Teo AKK; Stem Cells and Diabetes Laboratory, Institute of Molecular and Cell Biology (IMCB), A∗STAR, Proteos, Singapore, 138673, Singapore; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119228, Singapore; Department of Biochemistry, Yong Loo Lin S
  • Leclerc I; Section of Cell Biology and Functional Genomics, Imperial College London, du Cane Road, London, W12 0NN, UK.
  • Solimena M; Molecular Diabetology, University Hospital and Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany; Paul Langerhans Institute Dresden (PLID) of the Helmholtz Center Munich, University Hospital Carl Gustav Carus and Faculty of Medicine of the TU Dresden, Dresden, Germany; German Cente
  • Wigley DB; Section of Structural Biology, Department of Medicine, Imperial College London, London, UK.
  • Rutter GA; Section of Cell Biology and Functional Genomics, Imperial College London, du Cane Road, London, W12 0NN, UK. Electronic address: g.rutter@imperial.ac.uk.
Mol Metab ; 40: 101015, 2020 10.
Article de En | MEDLINE | ID: mdl-32416313
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Phosphoprotéines / Diabète de type 2 Limites: Animals Langue: En Journal: Mol Metab Année: 2020 Type de document: Article Pays d'affiliation: Royaume-Uni Pays de publication: Allemagne
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Phosphoprotéines / Diabète de type 2 Limites: Animals Langue: En Journal: Mol Metab Année: 2020 Type de document: Article Pays d'affiliation: Royaume-Uni Pays de publication: Allemagne